March 19 (Reuters) - Fate Therapeutics Inc:
* FATE THERAPEUTICS ANNOUNCES ADDITIONAL CLINICAL DATA FROM PHASE 1 STAGE OF PROTECT CLINICAL TRIAL OF PROTMUNE™
* FATE THERAPEUTICS INC - NO EVENTS OF CANCER RELAPSE HAVE OCCURRED WITH PROTMUNE IN PHASE 1 STAGE OF PROTECT Source text for Eikon: Further company coverage: